FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3212163773> ?p ?o ?g. }

• W3212163773 abstract "Diffuse large B-cell lymphoma (DLBCL) comprises at least two main biologically distinct entities: germinal center B-cell (GCB) and activated B-cell (ABC) subtype. Albeit sharing common lesions, GCB and ABC DLBCL present subtype-specific oncogenic pathway perturbations. ABC DLBCL is typically characterized by a constitutively active NF-kB. However, the latter is seen in also 30% of GCB DLBCL. Another recurrent lesion in DLBCL is an 11q24.3 gain, associated with the overexpression of two ETS transcription factors, ETS1 and FLI1. Here, we showed that FLI1 is more expressed in GCB than ABC DLBCL and we characterized its transcriptional network.Gene expression data were obtained from public datasets GSE98588, phs001444.v2.p1, GSE95013 and GSE10846. ChIP-Seq for FLI1 paired with transcriptome analysis (RNA-Seq) after FLI1 silencing (siRNAs) was performed. Sequencing was carried out using the NextSeq 500 (Illumina). Detection of peaks was done using HOMER (v2.6); differential expressed genes were identified using moderated t-test (limma R-package) and functionally annotated with g:Profiler. ChIP-Seq and RNA-Seq data from GCB DLBCL cell lines after FLI1 downregulation were integrated to identify putative direct targets of FLI1.Analysis of clinical DLBCL specimens showed that FLI1 gene was more frequently expressed at higher levels in GCB than in ABC DLBCL and its protein levels were higher in GCB than in ABC DLBCL cell lines. Genes negatively regulated by FLI1 included tumor suppressor genes involved in negative regulation of cell cycle and hypoxia. Among positively regulated targets of FLI1, we found genes annotated for immune response, MYC targets, NF-κB and BCR signaling and NOTCH pathway genes. Of note, direct targets of FLI1 overlapped with genes regulated by ETS1, the other transcription factor gained at the 11q24.3 locus in DLBCL, suggesting a functional convergence within the ETS family. Positive targets of FLI1 included the NF-κB-associated ASB2, a putative essential gene for DLBCL cell survival. ASB2 gene downregulation was toxic in GCB DLBCL cell lines and induced NF-κB inhibition via downregulation of RelB and increased IκBα. Additionally, downregulation of FLI1, but not ASB2, caused reduction of NF-κB1 and RelA protein levels.We conclude that FLI1 directly regulates a network of biologically crucial genes and processes in GCB DLBCL. FLI1 regulates both the classical NF-κB pathway at the transcriptional level, and the alternative NF-κB pathway, via ASB2. FLI1 and ASB2 inhibition represents a potential novel therapeutic approach for GCB DLBCL." @default.
• W3212163773 created "2021-11-22" @default.
• W3212163773 creator A5007167867 @default.
• W3212163773 creator A5012537023 @default.
• W3212163773 creator A5013066546 @default.
• W3212163773 creator A5014403308 @default.
• W3212163773 creator A5020962624 @default.
• W3212163773 creator A5032637306 @default.
• W3212163773 creator A5034455005 @default.
• W3212163773 creator A5037493613 @default.
• W3212163773 creator A5039188583 @default.
• W3212163773 creator A5047236032 @default.
• W3212163773 creator A5062054067 @default.
• W3212163773 creator A5066012620 @default.
• W3212163773 creator A5066518317 @default.
• W3212163773 creator A5073945848 @default.
• W3212163773 creator A5077930649 @default.
• W3212163773 date "2021-11-11" @default.
• W3212163773 modified "2023-10-14" @default.
• W3212163773 title "ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma" @default.
• W3212163773 cites W1076316180 @default.
• W3212163773 cites W1548926033 @default.
• W3212163773 cites W1605145036 @default.
• W3212163773 cites W1611787727 @default.
• W3212163773 cites W1789215739 @default.
• W3212163773 cites W1951934566 @default.
• W3212163773 cites W1971516612 @default.
• W3212163773 cites W1971659434 @default.
• W3212163773 cites W1984387148 @default.
• W3212163773 cites W2007006841 @default.
• W3212163773 cites W2014410888 @default.
• W3212163773 cites W2022272502 @default.
• W3212163773 cites W2035135710 @default.
• W3212163773 cites W2037796411 @default.
• W3212163773 cites W2055709915 @default.
• W3212163773 cites W2061903251 @default.
• W3212163773 cites W2078794317 @default.
• W3212163773 cites W2096465161 @default.
• W3212163773 cites W2098692163 @default.
• W3212163773 cites W2105066639 @default.
• W3212163773 cites W2112471382 @default.
• W3212163773 cites W2113869940 @default.
• W3212163773 cites W2114104545 @default.
• W3212163773 cites W2122260140 @default.
• W3212163773 cites W2130410032 @default.
• W3212163773 cites W2134526812 @default.
• W3212163773 cites W2137526110 @default.
• W3212163773 cites W2140063009 @default.
• W3212163773 cites W2144231724 @default.
• W3212163773 cites W2146512944 @default.
• W3212163773 cites W2160254534 @default.
• W3212163773 cites W2169456326 @default.
• W3212163773 cites W2326722293 @default.
• W3212163773 cites W2499999511 @default.
• W3212163773 cites W2515513475 @default.
• W3212163773 cites W2616561032 @default.
• W3212163773 cites W2762450632 @default.
• W3212163773 cites W2783139678 @default.
• W3212163773 cites W2797584152 @default.
• W3212163773 cites W2800080453 @default.
• W3212163773 cites W2801763724 @default.
• W3212163773 cites W2885976665 @default.
• W3212163773 cites W2944545583 @default.
• W3212163773 cites W2954022024 @default.
• W3212163773 cites W2999664171 @default.
• W3212163773 cites W3016044607 @default.
• W3212163773 cites W3107180188 @default.
• W3212163773 cites W3195024161 @default.
• W3212163773 doi "https://doi.org/10.1186/s13046-021-02159-3" @default.
• W3212163773 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8582153" @default.
• W3212163773 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34763718" @default.
• W3212163773 hasPublicationYear "2021" @default.
• W3212163773 type Work @default.
• W3212163773 sameAs 3212163773 @default.
• W3212163773 citedByCount "6" @default.
• W3212163773 countsByYear W32121637732022 @default.
• W3212163773 countsByYear W32121637732023 @default.
• W3212163773 crossrefType "journal-article" @default.
• W3212163773 hasAuthorship W3212163773A5007167867 @default.
• W3212163773 hasAuthorship W3212163773A5012537023 @default.
• W3212163773 hasAuthorship W3212163773A5013066546 @default.
• W3212163773 hasAuthorship W3212163773A5014403308 @default.
• W3212163773 hasAuthorship W3212163773A5020962624 @default.
• W3212163773 hasAuthorship W3212163773A5032637306 @default.
• W3212163773 hasAuthorship W3212163773A5034455005 @default.
• W3212163773 hasAuthorship W3212163773A5037493613 @default.
• W3212163773 hasAuthorship W3212163773A5039188583 @default.
• W3212163773 hasAuthorship W3212163773A5047236032 @default.
• W3212163773 hasAuthorship W3212163773A5062054067 @default.
• W3212163773 hasAuthorship W3212163773A5066012620 @default.
• W3212163773 hasAuthorship W3212163773A5066518317 @default.
• W3212163773 hasAuthorship W3212163773A5073945848 @default.
• W3212163773 hasAuthorship W3212163773A5077930649 @default.
• W3212163773 hasBestOaLocation W32121637731 @default.
• W3212163773 hasConcept C104317684 @default.
• W3212163773 hasConcept C119056186 @default.
• W3212163773 hasConcept C150194340 @default.
• W3212163773 hasConcept C159654299 @default.
• W3212163773 hasConcept C162317418 @default.
• W3212163773 hasConcept C203014093 @default.

• next